前置时间偏倚和永恒时间偏倚影响结肠镜后结直肠癌生存率的计算
该文讨论世界内镜组织(WEO)标准化报告结肠镜后结直肠癌(PCCRC)后,因病例定义相对于指数结肠镜,传统生存分析易受前置时间偏倚和永恒时间偏倚影响。基于Kaiser Permanente Northern California的10,938例检测出结直肠癌(93.8%)和717例PCCRC(6.2%)的回顾性队列,评估这些偏倚对死亡率的影响。
要点
- PCCRC占结直肠癌的7%至10%,于假阴性结肠镜后6至36个月诊断。
- 检测出结直肠癌于指数真阳性结肠镜后≤6个月诊断。
- PCCRC预后不明确,报告结局与检测出结直肠癌相当、更优或更差。
核心结论
- 传统生存分析PCCRC时易受前置时间偏倚和永恒时间偏倚影响,需评估这些偏倚对死亡率的影响。
研究设计与样本
- 基于Kaiser Permanente Northern California的回顾性队列,纳入10,938例检测出结直肠癌(93.8%)和717例PCCRC(6.2%)。
主要发现
- PCCRC占结直肠癌的7%至10%,于假阴性结肠镜后6至36个月诊断。
- 检测出结直肠癌于指数真阳性结肠镜后≤6个月诊断。
- PCCRC预后不明确,结局报告为与检测出结直肠癌相当、更优或更差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7.
引用
- Kang JH, Jensen CD, Merchant SA, et al. Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival. Clin Gastroenterol Hepatol. 2024. PMID: 38782174. doi:10.1016/j.cgh.2024.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。